INSMED INC
INSM · NASDAQ
更新於 2026-10-15 11:24:41
- 今日最高
- $98.00
- 今日最低
- $95.76
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $97.39
- 昨天收盤價
- $97.79
- 成交量
- 2.73M
- 市值
- $21.35B
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-4.10
昨天價格區間
52週價格區間
公司概況
- 板塊
- HEALTHCARE
- 行業
- Biotechnology
- 子行業
- BIOTECHNOLOGY
- 總部
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, UNITED STATES, 08807
- 國家
- US
- 上市日期
- 1991-02-15
- 財年截止
- December
- 流通股數
- 216.75M
- CIK
- 0001104506
- 官方網址
- insmed.com
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
財務指標
營業收入
2026-06-30
$425.48M
2026-03-31
$305.96M
2025-12-31
$263.84M
2025-09-30
$142.34M
營業支出
2026-06-30
$359.82M
2026-03-31
$456.74M
2025-12-31
$469.33M
2025-09-30
$478.98M
淨利潤
2026-06-30
-$13.24M
2026-03-31
-$163.56M
2025-12-31
-$328.48M
2025-09-30
-$370.02M
淨利潤率
2026-06-30
-3.11%
2026-03-31
-53.45%
2025-12-31
-124.5%
2025-09-30
-259.95%
每股收益
2026-06-30
$-0.52
2026-03-31
$-0.76
2025-12-31
$-1.54
2025-09-30
$-1.75
息稅折舊攤銷前利潤
2026-06-30
$14.16M
2026-03-31
-$137.1M
2025-12-31
-$302.15M
2025-09-30
-$345.66M
有效稅率
2026-06-30
-16.43%
2026-03-31
-0.9%
2025-12-31
-0.47%
2025-09-30
-0.35%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $425.48M | $305.96M | $263.84M | $142.34M |
| 營業支出 | $359.82M | $456.74M | $469.33M | $478.98M |
| 淨利潤 | -$13.24M | -$163.56M | -$328.48M | -$370.02M |
| 淨利潤率 | -3.11% | -53.45% | -124.5% | -259.95% |
| 每股收益 | $-0.52 | $-0.76 | $-1.54 | $-1.75 |
| 息稅折舊攤銷前利潤 | $14.16M | -$137.1M | -$302.15M | -$345.66M |
| 有效稅率 | -16.43% | -0.9% | -0.47% | -0.35% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。